» Articles » PMID: 9654066

Sulfhydryl Reagent Susceptibility in Proteins with High Sequence Similarity--triosephosphate Isomerase from Trypanosoma Brucei, Trypanosoma Cruzi and Leishmania Mexicana

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1998 Jul 8
PMID 9654066
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The amino acid sequence of triosephosphate isomerase from Trypanosoma brucei, Trypanosoma cruzi, and Leishmania mexicana have an identity of 68%. Using the numbering system for the T. brucei enzyme, in their aligned sequences, the T. cruzi and leishmanial enzymes have cysteine residues at positions 14, 40, 117 and 126. T. brucei triosephosphate isomerase has cysteine residues at positions 14, 40 and 126, and a valine residue at position 117. Dithionitrobenzoic acid and methylmethane thiosulfonate inhibited the three enzymes, but T. cruzi triosephosphate isomerase was more than 100-fold more sensitive. The sensitivity of wild type triosephosphate isomerase from T. cruzi and T. brucei to the reagents was equal to that of the Cys117Val and Val117Cys mutant enzymes, respectively. Triosephosphate isomerases that have cysteine residues at positions 40 and 126, but lack a cysteine residue at position 14 are insensitive to methylmethane thiosulfonate. Thus, sulfhydryl reagents act on Cys14. At stoichiometric concentrations, the reagents inhibited the three enzymes as a consequence of structural alterations as measured by binding of 8-anilino-1-napthalenesulfonic acid to previously buried hydrophobic regions. However, the times for half-maximal alterations were 10 min, 15 hours and over 30 hours for T. cruzi, T. brucei and L. mexicana triosephosphate isomerase, respectively. The effect of pH on the action of the sulfhydryl reagents and molecular modeling showed no differences in the solvent accessibility of Cys14. As Cys14 forms part of the dimer interface, the data indicate that, in the three enzymes, barriers of different magnitude hinder the interaction between the sulfhydryl reagents and Cys14. The barrier is lower in T. cruzi triosephosphate isomerase which makes its dimer interface more susceptible for perturbation.

Citing Articles

Targeted protein degradation might present a novel therapeutic approach in the fight against African trypanosomiasis.

Danazumi A, Ishmam I, Idris S, Izert M, Balogun E, Gorna M Eur J Pharm Sci. 2023; 186:106451.

PMID: 37088149 PMC: 11032742. DOI: 10.1016/j.ejps.2023.106451.


Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target.

Enriquez-Flores S, Flores-Lopez L, Garcia-Torres I, de la Mora-de la Mora I, Cabrera N, Gutierrez-Castrellon P Biomolecules. 2020; 10(7).

PMID: 32679775 PMC: 7407242. DOI: 10.3390/biom10071050.


Crystal structures of Triosephosphate Isomerases from Taenia solium and Schistosoma mansoni provide insights for vaccine rationale and drug design against helminth parasites.

Jimenez-Sandoval P, Castro-Torres E, Gonzalez-Gonzalez R, Diaz-Quezada C, Gurrola M, Camacho-Manriquez L PLoS Negl Trop Dis. 2020; 14(1):e0007815.

PMID: 31923219 PMC: 6980832. DOI: 10.1371/journal.pntd.0007815.


First characterization of a microsporidial triosephosphate isomerase and the biochemical mechanisms of its inactivation to propose a new druggable target.

Garcia-Torres I, de la Mora-de la Mora I, Hernandez-Alcantara G, Molina-Ortiz D, Caballero-Salazar S, Olivos-Garcia A Sci Rep. 2018; 8(1):8591.

PMID: 29872223 PMC: 5988755. DOI: 10.1038/s41598-018-26845-z.


Three unrelated and unexpected amino acids determine the susceptibility of the interface cysteine to a sulfhydryl reagent in the triosephosphate isomerases of two trypanosomes.

Diaz-Mazariegos S, Cabrera N, Perez-Montfort R PLoS One. 2018; 13(1):e0189525.

PMID: 29342154 PMC: 5771576. DOI: 10.1371/journal.pone.0189525.